KR102516049B1 - Vulvar cleaning composition that targets vaginitis bacteria - Google Patents
Vulvar cleaning composition that targets vaginitis bacteria Download PDFInfo
- Publication number
- KR102516049B1 KR102516049B1 KR1020220158288A KR20220158288A KR102516049B1 KR 102516049 B1 KR102516049 B1 KR 102516049B1 KR 1020220158288 A KR1020220158288 A KR 1020220158288A KR 20220158288 A KR20220158288 A KR 20220158288A KR 102516049 B1 KR102516049 B1 KR 102516049B1
- Authority
- KR
- South Korea
- Prior art keywords
- octenidine
- vulvar
- cleaning composition
- gram
- vulva
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 238000004140 cleaning Methods 0.000 title claims abstract description 45
- 206010046914 Vaginal infection Diseases 0.000 title claims abstract description 26
- 201000008100 Vaginitis Diseases 0.000 title claims abstract description 26
- 241000894006 Bacteria Species 0.000 title claims description 34
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 claims abstract description 42
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 38
- 229960001774 octenidine Drugs 0.000 claims abstract description 34
- 150000002989 phenols Chemical class 0.000 claims abstract description 21
- 230000008685 targeting Effects 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 210000003905 vulva Anatomy 0.000 claims description 34
- 239000006260 foam Substances 0.000 claims description 18
- 241000192125 Firmicutes Species 0.000 claims description 17
- 239000002781 deodorant agent Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 12
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 8
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 7
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 229940057070 sugarcane extract Drugs 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 4
- 239000005844 Thymol Substances 0.000 claims description 4
- -1 eucalyptus extract Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 229940041616 menthol Drugs 0.000 claims description 4
- 229960000790 thymol Drugs 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 229910021536 Zeolite Inorganic materials 0.000 claims description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 3
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 3
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 claims description 3
- 229940007062 eucalyptus extract Drugs 0.000 claims description 3
- 229940048866 lauramine oxide Drugs 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 229950008882 polysorbate Drugs 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- 230000002195 synergetic effect Effects 0.000 claims description 2
- 244000301850 Cupressus sempervirens Species 0.000 claims 1
- 239000004088 foaming agent Substances 0.000 abstract description 4
- 230000001580 bacterial effect Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000001877 deodorizing effect Effects 0.000 description 8
- 206010040880 Skin irritation Diseases 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 4
- 241001529453 unidentified herpesvirus Species 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 질염균을 표적항균하는 외음부 세정제 조성물에 관한 것이다.
일 실시예에 따르면, 질염을 유발하는 질염균을 선택적으로 표적항균하는 외음부 세정제 조성물에 있어서, 옥테니딘과 천연유래 페놀류 화합물 및 기포 형성제를 유효성분으로 함유하는 외음부 세정제 조성물이 제공될 수 있다.The present invention relates to a vulvar cleaning composition for targeting antibacterial vaginitis.
According to one embodiment, in the vulvar cleaner composition for selectively targeting antibacterial vaginitis causing vaginitis, the vulvar cleaner composition containing octenidine, a naturally-derived phenolic compound and a foaming agent as active ingredients can be provided. .
Description
본 발명은 질염균을 표적항균하는 외음부 세정제 조성물에 관한 것이다.The present invention relates to a vulvar cleaning composition for targeting antibacterial vaginitis.
여성 비뇨생식기계는 약산성을 유지하여 주는 유산간균이 상재하여 유해한 세균의 번식을 막아주는 역할을 하지만 물리적 손상, 호르몬 불균형 외에도 청결하지 않은 환경과 성관계에 따른 세균성 질환 또는 성병 등에 의해 각종 질환이 발생되기 쉽다.Lactobacillus, which maintains weak acidity, is present in the female genitourinary system to prevent the growth of harmful bacteria. However, in addition to physical damage and hormonal imbalance, various diseases are easily caused by unclean environment and bacterial or sexually transmitted diseases. .
이러한 각종 질환들을 예방하기 위하여, 다양한 외음부 세정제 조성물이 사용되고 있으며, 이러한 외음부 세정제 조성물의 대부분은 천연물 추출물, 유산균을 포함하는 천연물 소재와 1,2헥산디올, 에틸헥실글리세린, 벤조산나트륨을 포함하는 살균성분의 소재를 혼합하여 제조된다.In order to prevent these various diseases, various vulvar cleaning compositions are used, and most of these vulvar cleaning compositions are natural extracts, natural materials containing lactic acid bacteria, and bactericidal ingredients including 1,2 hexanediol, ethylhexylglycerin, and sodium benzoate It is made by mixing the materials of
그러나, 기존 외음부 세정제 조성물은 살균력이 약하고 안정성을 강조하여 실직적으로 효과를 보기 어려운 문제점이 있다.However, existing vulvar cleaning compositions have weak bactericidal power and emphasize stability, so it is difficult to see practical effects.
한편, 기존 외음부 세정제 조성물의 살균력을 증대시키기 위하여, 피부 세정분야의 제품들에 사용되는 옥테니딘 염산염을 적용하고자 하는 연구가 일부 진행되고 있으나, 옥테니딘 성분을 혼합할 때 제조공정 상의 한계점으로 에탄올, 페녹시에탄올과 같은 피부자극성이 높은 용매를 함께 사용해야하는 문제점이 있었다.On the other hand, in order to increase the sterilizing power of the existing vulva cleaning composition, some studies are being conducted to apply octenidine hydrochloride used in products in the skin cleaning field, but when mixing octenidine components, there are limitations in the manufacturing process. There was a problem in that solvents with high skin irritation, such as ethanol and phenoxyethanol, had to be used together.
이에 따라, 자극적인 물질을 사용하지 않고 안전하고 빠른 살균력이 있는 외음부 세정제 조성물의 개발이 관심을 받고 있으며, 더 구체적으로, 질 내부에서 젖산을 생산하는 질 유산균과 같은 유익균은 죽이지 않고 질염을 유발시키는 유해균만 선택적으로 죽일 수 있는 세정제 조성물의 개발이 필요하다.Accordingly, the development of a safe and fast sterilizing vulvar cleaner composition without using irritating substances is attracting attention, and more specifically, it does not kill beneficial bacteria such as vaginal lactic acid bacteria that produce lactic acid in the vagina and causes vaginitis. It is necessary to develop a detergent composition capable of selectively killing only harmful bacteria.
본 발명의 일 실시예에 따른 질염균을 표적항균하는 외음부 세정제 조성물은 상기와 같은 문제를 해결하기 위해 제안된 것으로서, 옥테니딘을 포함하더라도 피부자극성이 낮을 뿐만 아니라 청결유지를 통해 냄새와 염증을 방지하고, 선택적 항균활성을 가지는 외음부 세정제 조성물을 제공하고자 한다.The vulvar cleaner composition for target antibacterial vaginitis according to an embodiment of the present invention is proposed to solve the above problems, and even if it contains octenidine, it has low skin irritation and also eliminates odor and inflammation through cleanliness. To prevent, and to provide a vulvar cleaning composition having a selective antibacterial activity.
일 실시예에 따르면, 질염을 유발하는 질염균을 선택적으로 표적항균하는 외음부 세정제 조성물에 있어서, 옥테니딘과 천연유래 페놀류 화합물 및 기포 형성제를 유효성분으로 함유하는 외음부 세정제 조성물이 제공될 수 있다.According to one embodiment, in the vulvar cleaner composition for selectively targeting antibacterial vaginitis causing vaginitis, the vulva cleaner composition containing octenidine, a naturally-derived phenolic compound and a foaming agent as active ingredients can be provided. .
또한, 상기 옥테니딘은, 옥테니딘염산염(Octenidine dihydrochloride)인 외음부 세정제 조성물이 제공될 수 있다.In addition, the octenidine is octenidine hydrochloride (Octenidine dihydrochloride), the vulva cleaning composition may be provided.
또한, 상기 천연유래 페놀류 화합물은, 티몰, 멘톨 및 이소프로필메틸페놀로 이루어진 군에서 선택되는 어느 1종의 물질 또는 1종 이상의 물질을 포함하는 외음부 세정제 조성물이 제공될 수 있다.In addition, the vulva cleaner composition containing one or more substances selected from the group consisting of thymol, menthol, and isopropylmethylphenol as the naturally-derived phenolic compound may be provided.
또한, 상기 기포 형성제는, 코카미도프로필베타인, 코코베타인, 소듐라우로일귀리아미노산, 라우릴설페이트, 폴리소로베이트 및 라우라민옥사이드 중 선택되는 어느 1종의 물질 또는 1종 이상의 물질을 포함하는 외음부 세정제 조성물이 제공될 수 있다.In addition, the foam forming agent is any one material or one or more materials selected from cocamidopropyl betaine, coco betaine, sodium lauroyl oat amino acid, lauryl sulfate, polysorbate and lauramine oxide. A vulvar cleanser composition comprising can be provided.
또한, 상기 외음부 세정제 조성물은, 기포 유지제 및 소취제를 보조성분으로 더 함유하는 외음부 세정제 조성물이 제공될 수 있다.In addition, the vulva cleaning composition may be provided with a vulva cleaning composition further containing a bubble retaining agent and a deodorant as auxiliary components.
또한, 상기 기포 유지제는, 글리세린인 외음부 세정제 조성물이 제공될 수 있다.In addition, the foam retaining agent may be provided with glycerin in a vulva cleaning composition.
또한, 상기 기포 유지제는, 상기 외음부 세정제 조성물이 유효성분으로 상기 코카미도프로필베타인을 함유하는 경우에만 상기 외음부 세정제 조성물에 함유되는 외음부 세정제 조성물이 제공될 수 있다.In addition, the bubble-retaining agent is contained in the vulva cleaning composition only when the vulvar cleaning composition contains the cocamidopropyl betaine as an active ingredient, the vulvar cleaning composition may be provided.
또한, 상기 소취제는, 사탕수수 추출물, 편백나무 추출물, 레몬 추출물, 유칼리툽스 추출물 및 제올라이트 중 선택되는 어느 하나의 물질을 포함하는 외음부 세정제 조성물이 제공될 수 있다.In addition, the deodorant may be provided with a vulva cleaning composition containing any one material selected from sugar cane extract, cypress extract, lemon extract, eucalyptus extract, and zeolite.
또한, 상기 외음부 세정제 조성물은, 옥테니딘 0.01~5중량%, 천연유래 페놀류 화합물 0.01~1중량%, 기포 형성제 1~10중량%, 기포 유지제 0~1.5중량%, 소취제 0.05~0.15 중량% 및 정제수 90~97중량%로 이루어지는 외음부 세정제 조성물이 제공될 수 있다.In addition, the vulva cleaning composition includes 0.01 to 5% by weight of octenidine, 0.01 to 1% by weight of natural phenolic compounds, 1 to 10% by weight of foam forming agent, 0 to 1.5% by weight of foam retaining agent, and 0.05 to 0.15% by weight of deodorant. % and 90 to 97% by weight of purified water may be provided.
본 발명의 일 실시예에 따른 질염균을 표적항균하는 외음부 세정제 조성물은 옥테니딘을 포함하더라도 피부자극성이 낮을 뿐만 아니라 청결유지를 통해 냄새와 염증을 방지하고, 선택적 항균활성을 가지는 효과가 있다.The vulvar cleaner composition for target antibacterial vaginitis according to an embodiment of the present invention has low skin irritation even if it contains octenidine, prevents odor and inflammation through cleanliness, and has selective antibacterial activity.
도 1은 본 발명의 실시예들에 따른 질염균을 표적항균하는 외음부 세정제 조성물의 주요성분인 옥테니딘 및 이소프로필메틸페놀을 나타낸 도면이다.
도 2는 본 발명에 따른 실시예 1, 실시예 2와 비교예 1의 탈취력을 비교한 도면이다.
도 3은 본 발명에 실시예 1의 그람 양성균 및 그람 음성균에 살균력을 테스트한 결과를 나타낸 도면이다.
도 4는 본 발명의 실시예들에 따른 질염균을 표적항균하는 외음부 세정제 조성물의 선택적 항균활성 원리를 설명하기 위한 도면이다.
도 5는 본 발명에 실시예 1의 헤르페스 바이러스에 대한 살균력을 테스트한 결과를 나타낸 도면이다.1 is a view showing octenidine and isopropylmethylphenol, which are main components of a vulva cleaner composition for targeting antibacterial vaginitis according to embodiments of the present invention.
Figure 2 is a view comparing the deodorizing power of Examples 1 and 2 according to the present invention and Comparative Example 1.
3 is a view showing the results of testing the bactericidal power on Gram-positive bacteria and Gram-negative bacteria of Example 1 in the present invention.
Figure 4 is a view for explaining the principle of selective antibacterial activity of the vulva cleaning composition for targeting antibacterial vaginitis according to embodiments of the present invention.
5 is a view showing the results of testing the bactericidal power against the herpes virus of Example 1 in the present invention.
본 발명의 다른 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 상세하게 후술 되는 실시 예를 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시 예에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있으며, 단지 본 실시 예는 본 발명의 개시가 완전하도록 하고, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다.Other advantages and features of the present invention, and methods for achieving them, will become clear with reference to the embodiments described below in detail in conjunction with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below and may be implemented in various different forms, but only the present embodiments make the disclosure of the present invention complete, and the common knowledge in the art to which the present invention belongs It is provided to fully inform the holder of the scope of the invention, and the present invention is only defined by the scope of the claims.
만일 정의되지 않더라도, 여기서 사용되는 모든 용어들(기술 혹은 과학 용어들을 포함)은 이 발명이 속한 종래 기술에서 보편적 기술에 의해 일반적으로 수용되는 것과 동일한 의미를 가진다. 일반적인 사전들에 의해 정의된 용어들은 관련된 기술 그리고/혹은 본 출원의 본문에 의미하는 것과 동일한 의미를 갖는 것으로 해석될 수 있고, 그리고 여기서 명확하게 정의된 표현이 아니더라도 개념화되거나 혹은 과도하게 형식적으로 해석되지 않을 것이다.Even if not defined, all terms (including technical or scientific terms) used herein have the same meaning as generally accepted by common technology in the prior art to which this invention belongs. Terms defined by general dictionaries may be interpreted to have the same meaning as they have in the related art and/or the text of the present application, and are not conceptualized or overly formalized, even if not expressly defined herein. won't
본 명세서에서 사용된 용어는 실시 예들을 설명하기 위한 것이며 본 발명을 제한하고자 하는 것은 아니다. 본 명세서에서, 단수형은 문구에서 특별히 언급하지 않는 한 복수형도 포함한다. 명세서에서 사용되는 '포함한다' 및/또는 이 동사의 다양한 활용형들 예를 들어, '포함', '포함하는', '포함하고', '포함하며' 등은 언급된 조성, 성분, 구성요소, 단계, 동작 및/또는 소자는 하나 이상의 다른 조성, 성분, 구성요소, 단계, 동작 및/또는 소자의 존재 또는 추가를 배제하지 않는다. 본 명세서에서 '및/또는' 이라는 용어는 나열된 구성들 각각 또는 이들의 다양한 조합을 가리킨다.Terms used in this specification are for describing embodiments and are not intended to limit the present invention. In this specification, singular forms also include plural forms unless specifically stated otherwise in a phrase. As used in the specification, 'comprise' and/or various conjugations of this verb, such as 'comprise', 'comprising', 'comprising', 'comprising', etc., refer to a mentioned composition, ingredient, component, Steps, acts and/or elements do not preclude the presence or addition of one or more other compositions, ingredients, components, steps, acts and/or elements. In this specification, the term 'and/or' refers to each of the listed elements or various combinations thereof.
이하에서는 본 발명의 구체적인 실시예들에 대하여 도면을 참조하여 상세히 설명한다.Hereinafter, specific embodiments of the present invention will be described in detail with reference to the drawings.
아울러 본 발명을 설명함에 있어서, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명을 생략한다.In addition, in describing the present invention, if it is determined that a detailed description of a related known configuration or function may obscure the gist of the present invention, the detailed description will be omitted.
본 발명에서는 옥테니딘에 적어도 1종의 천연유래 페놀류 화합물과 적어도 1종의 기포 형성제를 포함하되, 기포 유지제 및 소취제를 더 포함하도록 제조됨으로써, 옥테니딘의 장점인 살균력을 극대화시키고, 옥테니딘의 단점인 피부자극을 완화시킬 수 있으며, 냄새와 염증을 방지하고, 선택적으로 질염균을 항균할 수 있도록 설계된 외음부 세정제 조성물을 확보하였다.In the present invention, octenidine is prepared to include at least one naturally occurring phenolic compound and at least one foam forming agent, but further include a foam retaining agent and a deodorant, thereby maximizing the bactericidal power, which is an advantage of octenidine, A vulvar cleaner composition designed to alleviate skin irritation, which is a disadvantage of octenidine, prevent odor and inflammation, and selectively antibacterial vaginitis was secured.
더하여, 본 발명의 외음부 세정제 조성물은 화장품으로 분류되는 인체세정제로 사용할 수 있는 것이며, 구체적으로 외음부 청결을 목적으로 사용하는 세정제이다.In addition, the vulvar cleaning composition of the present invention can be used as a human body cleaning agent classified as cosmetics, and is specifically a cleaning agent used for the purpose of cleaning the vulva.
또한, 본 발명의 외음부 세정제 조성물은 의약외품으로 분류되는 외음부 소독제로 사용할 수 있는 것이며, 구체적으로 감염 방지를 위해 피부에 살균, 소독을 목적으로 사용하는 소독제이다.In addition, the vulva cleaning composition of the present invention can be used as a vulvar disinfectant classified as a quasi-drug, and is specifically a disinfectant used for sterilization and disinfection of the skin to prevent infection.
즉, 본 발명은 외음부의 청결 및 미화를 목적으로하고 인체에 대한 작용이 경미한 여성청결제 제품으로 사용될 수 있는 것이며, 더 나아가, 본 발명은 외음부의 염증 치료 및 예방을 목적으로하고 화장품보다는 작용이 강하며 의약품보다는 인체에 대한 작용이 약한 여성용소독제 제품으로 사용될 수 있다.That is, the present invention can be used as a feminine cleanser product for the purpose of cleaning and beautifying the vulva and having a slight action on the human body, and furthermore, the present invention is aimed at treating and preventing inflammation of the vulva and has a stronger action than cosmetics It can be used as a female disinfectant product with weaker effects on the human body than pharmaceuticals.
도 1은 본 발명의 실시예들에 따른 질염균을 표적항균하는 외음부 세정제 조성물의 주요성분인 옥테니딘 및 이소프로필메틸페놀을 나타낸 도면이다.1 is a view showing octenidine and isopropylmethylphenol, which are main components of a vulva cleaner composition for targeting antibacterial vaginitis according to embodiments of the present invention.
도 1a)는 본 발명에 따른 옥테니딘의 구조이고, 도 1b)는 본 발명에 따른 이소프로필메틸페놀의 구조를 나타낸다.Figure 1a) shows the structure of octenidine according to the present invention, Figure 1b) shows the structure of isopropylmethylphenol according to the present invention.
따라서, 본 발명의 실시예들에 따른 질염균을 표적항균하는 외음부 세정제 조성물은 옥테니딘, 천연유래 페놀류 화합물, 기포 형성제, 기포유지제, 소취제 및 정제수로 이루어지는 외음부 세정제 조성물에 관한 것이다.Therefore, the vulvar cleaning composition for targeting antibacterial vaginitis according to embodiments of the present invention relates to a vulvar cleaning composition comprising octenidine, a naturally-derived phenolic compound, a foam forming agent, a foam holding agent, a deodorant, and purified water.
먼저, 도 1을 참조하면, 상기 외음부 세정제 조성물은 옥테니딘과 천연유래 페놀류 화합물 및 기포 형성제를 유효성분으로 함유한다.First, referring to FIG. 1, the vulva cleaning composition contains octenidine, a naturally-derived phenolic compound, and a foaming agent as active ingredients.
여기서, 상기 옥테니딘은 옥테니딘염산염(Octenidine dihydrochloride)이며, 볼라-암프파일 구조(Bolaamphiphiles)를 갖는 제네미 계면활성제(Gemini Surfactant)로 음극의 세포 표면에 강하게 흡착되어 세포막의 인지질(phospholipid) 및 미생물 세포벽의 음이온 다당류와 반응하고, 효소계를 간섭하며, 세포기능을 방해하여 원형질막의 누수를 초래하여, 그 결과 미토콘드리아의 기능을 저해하여 우수한 미생물 살균효과를 나타내며, 상기 천연유래 페놀류 화합물 및 상기 기포 형성제와 함께 시너지 효과를 나타내어 그람 양성균과 그람 음성균 중 상기 그람 음성균을 선택적으로 살균하는 효과를 제공한다. Here, the octenidine is octenidine dihydrochloride, which is a geminisurfactant having a Bolaamphiphiles structure that is strongly adsorbed on the cell surface of the cathode to form a phospholipid of the cell membrane. and reacts with the anionic polysaccharide of the cell wall of microorganisms, interferes with the enzyme system, interferes with cell function, resulting in leakage of the plasma membrane, and as a result, inhibits the function of mitochondria to exhibit excellent microbial sterilization effect. It shows synergistic effect with the forming agent to provide an effect of selectively sterilizing the gram-negative bacteria among gram-positive bacteria and gram-negative bacteria.
이 때, 그람 음성균은 내부 세포질막과 외막 사이에 얇은 펩타이드 글리칸 세포벽이 샌드위치 모양처럼 구성된 특징을 가지며, 질염을 유발하는 균을 총칭하는 질염균이 상기 그람 음성균에 해당한다.At this time, Gram-negative bacteria have a feature of having a thin peptide glycan cell wall between the inner cytoplasmic membrane and the outer membrane like a sandwich, and vaginitis, which is a general term for bacteria that cause vaginitis, corresponds to the Gram-negative bacteria.
그람 양성균은 상기 그람 음성균과 비교하였을 때, 외막이 없는 특징을 가지며, 질 내부에서 젖산을 생산하는 질 유산균이 상기 그람 양성균에 해당한다.Compared with the gram-negative bacteria, gram-positive bacteria have a characteristic of not having an outer membrane, and vaginal lactic acid bacteria that produce lactic acid in the vagina correspond to the gram-positive bacteria.
또한, 상기 천연유래 페놀류 화합물은 티몰, 멘톨 및 이소프로필메틸페놀로 이루어진 군에서 선택되는 어느 1종의 물질 또는 1종 이상의 물질을 포함할 수 있다.In addition, the naturally-derived phenol compound may include any one material or one or more materials selected from the group consisting of thymol, menthol, and isopropylmethylphenol.
상기 천연유래 페놀류 화합물은 숙련된 기술자의 능력 내에서 공지된 방법에 의하여 합성적으로 제조될 수 있거나, 또는 식물 오일 추출물로부터 얻어질 수 있다.The naturally occurring phenolic compounds may be prepared synthetically by known methods within the ability of a skilled person, or may be obtained from plant oil extracts.
본 발명의 바람직한 실시예들에서, 천연유래 페놀류 화합물은 식물 추출물로부터 얻어지거나, 시판된 제품을 사용할 수 있다.In preferred embodiments of the present invention, the naturally-derived phenolic compounds may be obtained from plant extracts or commercially available products.
이러한, 상기 천연유래 페놀류 화합물은 상기 옥테니딘의 살균범위를 조절할 수 있는 특징이 있으며, 구체적으로, 상기 옥테니딘의 그람 양성균에 대한 살균력을 저하시킨다.These naturally-derived phenolic compounds are characterized by being able to control the sterilizing range of the octenidine, and specifically, lower the sterilizing power of the octenidine against Gram-positive bacteria.
상기 기포 형성제는 코카미도프로필베타인, 코코베타인, 소듐라우로일귀리아미노산, 라우릴설페이트, 폴리소로베이트 및 라우라민옥사이드 중 선택되는 어느 1종의 물질 또는 1종 이상의 물질을 포함한다.The foam forming agent includes one or more materials selected from among cocamidopropyl betaine, cocobetaine, sodium lauroyl oat amino acid, lauryl sulfate, polysorbate, and lauramine oxide.
기포 형성제는 천연 계면활정제로, 피부점막을 자극하지 않는 순한 성질을 가지는 특징이 있으며, 피부자극을 주여주고 점도를 올려준다. 또한, 우수한 세정력, 기포력, 증점력을 가지며, 정전기 방지 효과 및 컨디셔닝 효과를 가지는 특징이 있다.The bubble forming agent is a natural surfactant and has a mild property that does not irritate the skin mucous membrane, gives skin irritation and increases viscosity. In addition, it has excellent cleaning power, foaming power, and thickening power, and has characteristics of having an antistatic effect and a conditioning effect.
이러한, 상기 기포 형성제는 상기 옥테니딘의 살균 효과를 활성화시킬 수 있어 살균 및 소독 효과를 증진시킬 수 있는 특징이 있으며, 구체적으로, 상기 옥테니딘의 그람 음성균에 대한 살균작용이 활성화될 수 있도록 기포를 기 설정된 시간동안 형성한다.The foam-forming agent can activate the sterilization effect of the octenidine and thus enhance the sterilization and disinfection effect. Bubbles are formed for a predetermined time so that
이 때, 상기 기 설정된 시간은 10 내지 20분의 범위를 만족하는 유지시간일 수 있다.At this time, the preset time may be a holding time that satisfies a range of 10 to 20 minutes.
구체적으로, 상기 기포 형성제는 상기 옥테니딘의 살균작용을 활성화시키는 역할을 하는 반면에, 상기 옥테니딘의 살균력을 억제하는 역할을 할 수 있으며, 더 구체적으로, 상기 외음부 세정제 조성물 100중량%에 대하여, 1중량%를 초과하도록 함으로써, 그람 양성균에 대한 살균작용이 활성화되지 않고, 그람 음성균에 대한 살균작용만 활성화될 수 있도록 한다.Specifically, the foam former serves to activate the sterilizing action of the octenidine, while inhibiting the sterilizing power of the octenidine, and more specifically, 100% by weight of the vulva cleaner composition With respect to, by exceeding 1% by weight, the bactericidal action against gram-positive bacteria is not activated, and only the bactericidal action against gram-negative bacteria can be activated.
다음으로, 상기 외음부 세정제 조성물은 기포 유지제 및 소취제를 보조성분으로 더 함유할 수 있다.Next, the vulva cleaning composition may further contain a foam retaining agent and a deodorant as auxiliary components.
상기 기포 유지제는, 글리세린으로, 보습성과 점성이 강한 특징이 있으며, 일반적인 화장품에 널리 사용되고 있다.The cell-retaining agent is glycerin, which is characterized by strong moisturizing properties and viscosity, and is widely used in general cosmetics.
기포 유지제는 무색투명 하고 점성이 있는 액체로 흡습성이 강하고, 혼합물을 균질하게 분산시킬 수 있다. 또한, 공기 중의 수분을 흡수하여 피부에 공급하고 외부 자극으로부터 피부를 보호할 수 있다. The foam retaining agent is a colorless, transparent, and viscous liquid that has strong hygroscopicity and can homogeneously disperse the mixture. In addition, it can absorb moisture in the air, supply it to the skin, and protect the skin from external stimuli.
즉, 기포 유지제는 상기 외음부 세정제의 수분발산을 억제시키고, 경도, 점도를 안정시킬 수 있는 특징이 있으며, 또한, 상기 기포 형성제에 의해 형성된 기포를 오랜시간동안 유지시키는 역할을 한다.That is, the bubble retaining agent has the characteristics of suppressing the emission of water of the vulva cleaner, stabilizing the hardness and viscosity, and also serves to maintain the bubbles formed by the bubble forming agent for a long time.
구체적으로, 상기 기포 유지제는 상기 기포 형성제가 기포를 형성하여 상기 옥테니딘의 그람 음성균에 대한 살균작용이 활성화되더라도, 기포가 빠른시간 내에 사라지는 것을 방지하여, 상기 옥테니딘의 살균작용 활성화를 오랜시간동안 유지시킨다.Specifically, the bubble retaining agent prevents bubbles from quickly disappearing even when the bubble forming agent forms bubbles and the bactericidal action of octenidine against gram-negative bacteria is activated, thereby activating the bactericidal action of octenidine. keep for a long time
한편, 본 발명의 실시예들에서, 상기 기포 유지제는 상기 외음부 세정제 조성물이 유효성분으로 상기 코카미도프로필베타인을 함유하는 경우에만 상기 외음부 세정제 조성물에 함유될 수 있다.On the other hand, in the embodiments of the present invention, the bubble retaining agent may be contained in the vulva cleaning composition only when the vulvar cleaning composition contains the cocamidopropyl betaine as an active ingredient.
만약, 상기 외음부 세정제 조성물이 유효성분으로 코마미도프로필베타인을 대체하여 소듐라우로일귀리아미노산을 함유하는 경우에는 상기 기포 유지제가 함유되지 않는 것이 바람직하다.If the vulva cleaning composition contains sodium lauroyl oat amino acid by replacing comamidopropyl betaine as an active ingredient, it is preferable that the foam retaining agent is not contained.
상기 소취제는 사탕수수 추출물, 편백나무 추출물, 레몬 추출물, 유칼리툽스 추출물 및 제올라이트 중 선택되는 어느 하나의 물질을 포함할 수 있다.The deodorant may include any one material selected from sugar cane extract, cypress tree extract, lemon extract, eucalyptus extract, and zeolite.
소취제는 상기 외음부 세정제의 자극적인 향으로 인하여 상품성을 저하시키는 근본적인 원인을 우수한 소취 효과를 통해 현저히 감소시킬 수 있다.The deodorant can significantly reduce the fundamental cause of deteriorating marketability due to the irritating scent of the vulva cleaner through an excellent deodorizing effect.
본 발명의 바람직한 실시예들에서는 상기 소취제로 사탕수수 추출물을 사용하며, 상기 사탕수수 추출물은 폴리코사놀(polycosanol) 뿐만 아니라 마그네슘, 칼슘, 비타민 B, 칼륨 등의 성분을 함유하므로 항암작용, 보습작용, 수분보충 및 노화피부 활력 개선 효과가 우수하다. 또한, 상기 사탕수수 추출물은 유기산, 플라본계 화합물, 페놀계 화합물 및 불포화 알데히드등 악취물질과 반응하여 화학적 탈취 효과가 우수하므로, 상기 외음부 세정제 조성물이 보유하는 불쾌한 향을 저감시킬 수 있다.In preferred embodiments of the present invention, sugarcane extract is used as the deodorant, and the sugarcane extract contains not only polycosanol, but also magnesium, calcium, vitamin B, and potassium, so it has anticancer action, moisturizing action, and moisture. Replenishment and aging skin vitality improvement effect is excellent. In addition, since the sugarcane extract reacts with odorous substances such as organic acids, flavone-based compounds, phenolic compounds and unsaturated aldehydes, and has an excellent chemical deodorizing effect, the unpleasant odor possessed by the vulva cleaning composition can be reduced.
이상, 설명한 바와 같이, 본 발명의 실시예들에 따른 질염균을 표적항균하는 외음부 세정제 조성물은 옥테니딘 0.01~5중량%, 천연유래 페놀류 화합물 0.01~1중량%, 기포 형성제 1~10중량%, 기포 유지제 0~1.5중량%, 소취제 0.05~0.15 중량% 및 정제수 90~97중량%로 이루어질 수 있다.As described above, the vulva cleaning composition for target antibacterial vaginitis according to embodiments of the present invention contains 0.01 to 5% by weight of octenidine, 0.01 to 1% by weight of a natural phenolic compound, and 1 to 10% by weight of a foaming agent. %, it may consist of 0 to 1.5% by weight of a bubble retaining agent, 0.05 to 0.15% by weight of a deodorant, and 90 to 97% by weight of purified water.
더 구체적으로, 상기 천연유래 페놀류 화합물의 함량을 높이면, 상기 옥테니딘의 살균력이 증대되어 그람 양성균 및 그람 음성균을 모두 죽일 수 있으므로, 본 발명의 바람직한 실시예에서는 상기 그람 음성균만 표적항균하기 위하여 상기 천연유래 페놀류 화합물은 1중량%를 초과하지 않도록 한다.More specifically, when the content of the naturally-derived phenolic compound is increased, the bactericidal power of the octenidine is increased to kill both gram-positive bacteria and gram-negative bacteria. Natural-derived phenolic compounds should not exceed 1% by weight.
또한, 상기 기포 형성제의 함량을 낮추면, 상기 옥테니딘의 살균력이 크게 증가하여 그람 양성균까지 죽일 수 있으므로, 본 발명의 바람직한 실시예에서는 상기 그람 음성균만 표적항균하기 위하여 상기 기포 형성제는 1중량%를 초과하도록 한다.In addition, if the content of the foam-forming agent is lowered, the bactericidal power of the octenidine is greatly increased to kill even Gram-positive bacteria. to exceed %.
이하, 실시예를 통해, 본 발명을 더욱 구체적으로 상술하나 하기 실시예에 의해 본 발명이 제한되지 아니함은 자명하다.Hereinafter, the present invention will be described in more detail through examples, but it is obvious that the present invention is not limited by the following examples.
실시예 1 내지 4 : 외음부 세정제 조성물의 제조 Examples 1 to 4: Preparation of vulva cleaning composition
상기 외음부 세정제 조성물의 약한 피부자극성, 냄새와 염증 방지 및 선택적 항균활성작용 효과를 검증하기 위하여 외음부 세정제 조성물을 제조하고, 그 함량을 구체적으로 표 1에 나타내었다.In order to verify the effect of the weak skin irritation, odor and inflammation prevention and selective antibacterial activity of the vulvar cleaning composition, a vulvar cleaning composition was prepared, and the contents thereof are specifically shown in Table 1.
비교예 1 : 시판 외음부 세정제 조성물의 준비 Comparative Example 1: Preparation of commercially available vulvar cleaning composition
시중에 판매되고 있으며, 옥테니딘을 함유하지 않고, 천연물 추출물과 벤조산나트륨과 같은 살균성분만을 포함하는 시판 외음부 세정제 조성물을 준비하였다.A commercially available vulvar cleaner composition was prepared that is commercially available, does not contain octenidine, and contains only natural extracts and bactericidal components such as sodium benzoate.
실험예 1 : 관능평가Experimental Example 1: Sensory evaluation
본 발명의 실시예 1 내지 실시예 3과 비교예 1의 외음부 세정제 조성물의 효능을 평가하기 위하여, 나이에 관계없이 지원자 여성 20명에 대해 관능평가를 실시하고 그 결과를 표 2에 나타내었다.In order to evaluate the efficacy of the vulvar cleaning compositions of Examples 1 to 3 and Comparative Example 1 of the present invention, sensory evaluation was performed on 20 female applicants regardless of age, and the results are shown in Table 2.
본 효능실험에 동의한 여성들은 평소에 특이취를 느끼지만 신체적 이상이 있지는 않았으며, 1일 아침, 저녁으로 2회, 1회당 실시예 1 내지 실시예 3과 비교예 1의 조성물을 손으로 질 내부와 외부에 적용한 후 충분히 헹구어 내는 방식으로 각각 1주간 사용하도록 하였다.Women who agreed to this efficacy test usually felt a peculiar smell, but did not have any physical abnormalities, and they applied the compositions of Examples 1 to 3 and Comparative Example 1 twice a day, morning and evening, each time inside the vagina with their hands. After applying it externally, it was used for 1 week, respectively, by rinsing thoroughly.
상기 관능평가에서, 표 2를 참조하면, 이소프로필메틸페놀을 함유한 실시예 3은 자극과 냄새가 없었으며, 기포가 가장 오래 유지되는 것을 확인하였다. 또한, 실시예 1은 약한 취가 있었고, 실시예 2는 취는 없었으나 약한 자극이 있는 것으로 확인되었다. 더하여, 실시예 1 내지 실시예 3를 살펴보면 비교예 1에 비해서 기포의 유지시간이 3배이상인 것을 확인할 수 있다.In the sensory evaluation, referring to Table 2, Example 3 containing isopropylmethylphenol had no irritation and odor, and it was confirmed that bubbles were maintained the longest. In addition, Example 1 had a weak odor, and Example 2 had no odor, but it was confirmed that there was a slight irritation. In addition, looking at Examples 1 to 3, it can be seen that the retention time of bubbles is three times or more compared to Comparative Example 1.
실험예 2 : 탈취력 평가Experimental Example 2: Evaluation of deodorizing power
본 발명의 실시예 3, 실시예 4, 비교예 1의 탈취력 평가를 위하여, 아밀라아제 5g에 실시예3, 실시예 4 및 비교예 1의 조성물을 각각 1g 씩 투여하고, 그 결과를 도 2에 나타내었다.In order to evaluate the deodorizing power of Examples 3, 4 and Comparative Example 1 of the present invention, 1 g of each of the compositions of Examples 3, 4 and Comparative Example 1 was administered to 5 g of amylase, and the results are shown in FIG. was
도 2는 본 발명에 따른 실시예 3, 실시예 4와 비교예 1의 탈취력을 비교한 도면이다.Figure 2 is a view comparing the deodorizing power of Examples 3 and 4 according to the present invention and Comparative Example 1.
도 2에 도시된 바와 같이, 기포 형성제의 종류에 따라 탈취력의 차이가 있는 것을 확인할 수 있으며, 실시예 3과 실시예 4는 비교예 1보다 향상된 탈취력을 가지는 것을 확인하였다.As shown in FIG. 2, it can be confirmed that there is a difference in deodorizing power depending on the type of bubble forming agent, and it was confirmed that Examples 3 and 4 have improved deodorizing power than Comparative Example 1.
실험예 3 : 소취시험 평가Experimental Example 3: Deodorization test evaluation
본 발명의 실시예 1과 실시예 3을 KSI 2218 시험법으로 소취시험을 진행하고, 그 결과를 표 3에 나타내었다.Examples 1 and 3 of the present invention were subjected to a deodorization test according to the KSI 2218 test method, and the results are shown in Table 3.
표 3을 참조하면, 실시예 3은 95%의 냄새 감소율을 보이는 것을 확인하였다.Referring to Table 3, it was confirmed that Example 3 showed a 95% odor reduction rate.
실험예 4 : 선택적 표적항균시험 평가Experimental Example 4: Selective target antibacterial test evaluation
본 발명의 실시예 3이 질염균을 포함하는 그람 음성균에 대해 선택적 살균하는지 살펴보기 위해, ASTM E2315-16 시험을 실시하고, 그 결과를 표 4와 그림 3에 나타내었다. In order to examine whether Example 3 of the present invention selectively sterilizes Gram-negative bacteria including vaginitis, the ASTM E2315-16 test was conducted, and the results are shown in Table 4 and Figure 3.
이 때, 그람 양성균은 대체균으로 황색포도상구균을 사용하였고, 그람 음성균은 대체균으로 질염균과 구조가 비슷한 대장균을 배양하여 시험을 진행하였다.At this time, Staphylococcus aureus was used as a substitute for Gram-positive bacteria, and Escherichia coli, which has a similar structure to vaginitis, was cultured and tested as a substitute for Gram-negative bacteria.
표 4와 도 3을 참조하면, 실시예 3은 접촉시간 15초 안에 그람음성균이 99.99% 사멸한 것을 확인할 수 있다.Referring to Table 4 and FIG. 3, in Example 3, it can be confirmed that 99.99% of Gram-negative bacteria were killed within 15 seconds of contact time.
좀 더 구체적으로 설명하면, 비커에 그람 양성균과 그람 음성균을 각각 배양(Control)한 후, 상기 실시예 3을 투입하여 15초간 접촉시키고, 다시 그람 양성균과 그람 음성균을 배양하였을 때, 그람 양성균은 약 5%가 살아 남아 다시 세포분열하여 그 수가 증가하였으며, 그람 음성균은 99% 가 박멸되었다.More specifically, after culturing (control) gram-positive bacteria and gram-negative bacteria in a beaker, the Example 3 was added and contacted for 15 seconds, and when the gram-positive bacteria and gram-negative bacteria were cultured again, the gram-positive bacteria were about 5% survived and re-divided to increase their number, and 99% of Gram-negative bacteria were eradicated.
이는, 실시예 3의 선택적 항균활성으로 그람 음성균을 선택적으로 살균하는 것을 의미하며, 다시 말해, 실시예 3이 질염균을 표적항균하는 효능을 가진다는 것을 의미하며, 상기 선택적 항균활성 원리는 아래 도 4를 통해 설명한다.This means that Gram-negative bacteria are selectively sterilized with the selective antibacterial activity of Example 3, in other words, that Example 3 has the efficacy of target antibacterial vaginitis. explained through 4.
도 4는 본 발명의 실시예들에 따른 질염균을 표적항균하는 외음부 세정제 조성물의 선택적 항균활성 원리를 설명하기 위한 도면이다.Figure 4 is a view for explaining the principle of selective antibacterial activity of the vulva cleaning composition for targeting antibacterial vaginitis according to embodiments of the present invention.
도 4a)는 실시예 3과 그람 양성균의 접촉 구조를 나타낸 도면이고, 도 4b)는 실시예 3과 그람 음성균의 접촉 구조를 나타낸 도면이다.4a) is a diagram showing the contact structure between Example 3 and Gram-positive bacteria, and FIG. 4b) is a diagram showing the contact structure between Example 3 and Gram-negative bacteria.
도 4를 참조하면, 실시예 3의 천연유래 페놀류 화합물인 이소프로필메틸페놀은 OH- 기로 인하여, 상기 옥테니딘 염산염이 부착되어 그람 양성균의 펩타이드 글리칸 층을 살균하는데 방해가 되므로 살균에 한계점이 있다. 그러나, 실시예 3의 옥테니딘 염산염은 천연유래 페놀류 화합물의 방해 없이 세포막의 인지질과 반응하므로 이러한 원리를 통해 선택적으로 그람 음성균만을 효율적으로 박멸할 수 있다.Referring to FIG. 4, isopropylmethylphenol, a naturally-derived phenolic compound of Example 3, has a limitation in sterilization because the octenidine hydrochloride is attached to it due to its OH- group and interferes with sterilizing the peptide glycan layer of Gram-positive bacteria. there is. However, since octenidine hydrochloride of Example 3 reacts with phospholipids of cell membranes without hindrance of naturally occurring phenolic compounds, only Gram-negative bacteria can be selectively and efficiently eradicated through this principle.
실험예 5 : 살진균 시험Experimental Example 5: fungicide test
본 발명의 따른 실시예 3의 칸디다균에 대한 진균력 평가를 위해, ASTM E2315-16 시험을 실시하고, 그 결과를 표 5에 나타내었다.To evaluate the fungal activity against Candida of Example 3 according to the present invention, the ASTM E2315-16 test was conducted, and the results are shown in Table 5.
(C.albicans)fungicide test
(C. albicans)
표 5를 참조하면, 실시예 3은 칸디다균이 15초에서 99.99% 살균되는 것을 확인할 수 있다.Referring to Table 5, in Example 3, it can be confirmed that Candida bacteria are 99.99% sterilized in 15 seconds.
실험예 6 : 항바이러스 시험Experimental Example 6: Antiviral test
본 발명의 따른 실시예 3의 herpes virus 1에 대한 항바이러스 평가를 위해, ASTM E1052 시험을 실시하고, 그 결과를 표 6에 나타내었다.For antiviral evaluation against
(herpes virus 1)antiviral
(herpes virus 1)
표 6을 참조하면, 실시예 3은 성매개체 감염으로 포진을 일으키는 헤르페스 바이러스에 대해서도 높은 살균력을 가짐을 확인하였다.Referring to Table 6, Example 3 was confirmed to have high bactericidal power against the herpes virus that causes herpes as a sexually transmitted infection.
이상 본 발명의 실시예에 따른 질염균을 표적항균하는 외음부 세정제 조성물을 구체적인 실시 형태로서 설명하였으나, 이는 예시에 불과한 것으로서 본 발명은 이에 한정되지 않는 것이며, 본 명세서에 개시된 기초 사상에 따르는 최광의 범위를 갖는 것으로 해석되어야 한다. 당업자는 개시된 실시 형태들을 조합, 치환하여 적시되지 않은 실시 형태를 실시할 수 있으나, 이 역시 본 발명의 권리범위를 벗어나지 않는 것이다. 이외에도 당업자는 본 명세서에 기초하여 개시된 실시형태를 용이하게 변경 또는 변형할 수 있으며, 이러한 변경 또는 변형도 본 발명의 권리범위에 속함은 명백하다.Although the vulvar cleaner composition for targeting antibacterial vaginitis according to an embodiment of the present invention has been described as a specific embodiment, this is only an example and the present invention is not limited thereto, and the widest scope according to the basic idea disclosed herein should be interpreted as having A person skilled in the art may implement an embodiment that is not indicated by combining or substituting the disclosed embodiments, but this also does not deviate from the scope of the present invention. In addition, those skilled in the art can easily change or modify the disclosed embodiments based on this specification, and it is clear that such changes or modifications also fall within the scope of the present invention.
Claims (9)
옥테니딘과 이소프로필메틸페놀로 이루어진 천연유래 페놀류 화합물 및 코카미도프로필베타인으로 이루어진 기포 형성제를 유효성분으로 함유하고, 기포 유지제 및 소취제를 보조성분으로 함유하되,
상기 외음부 세정제 조성물은,
옥테니딘 0.01~5중량%, 천연유래 페놀류 화합물 0.01~1중량%, 기포 형성제 2~9중량%, 기포 유지제 0~1.5중량%, 소취제 0.05~0.15 중량% 및 정제수 90~97중량%로 이루어지고,
상기 옥테니딘은 상기 천연유래 페놀류 화합물 및 상기 기포 형성제와 함께 시너지 효과를 나타냄에 따라 상기 질염균인 그람 양성균 및 그람 음성균 중 상기 그람 음성균의 외막에 부착되어 상기 그람 음성균을 선택적으로 살균하되,
상기 천연유래 페놀류 화합물은 상기 옥테니딘의 상기 그람 양성균에 대한 살균력을 저하시켜 상기 옥테니딘의 살균범위를 조절하고,
상기 기포 형성제는 상기 옥테니딘의 살균작용이 활성화될 수 있도록 기포를 형성하고,
상기 기포 유지제는 상기 외음부 세정제 조성물의 수분발산을 억제시키는 동시에 상기 기포 형성제에 의해 형성된 기포를 유지시키는, 외음부 세정제 조성물.
In the vulvar cleaning composition for selectively targeting antibacterial vaginitis causing vaginitis,
It contains a naturally-derived phenolic compound composed of octenidine and isopropylmethylphenol and a bubble forming agent composed of cocamidopropyl betaine as active ingredients, and contains a bubble retaining agent and a deodorant as auxiliary ingredients,
The vulva cleaning composition,
Octenidine 0.01 to 5% by weight, natural phenolic compounds 0.01 to 1% by weight, foam former 2 to 9% by weight, foam retaining agent 0 to 1.5% by weight, deodorant 0.05 to 0.15% by weight and purified water 90 to 97% by weight made up of,
As the octenidine exhibits a synergistic effect with the naturally-derived phenolic compound and the foam-forming agent, it is attached to the outer membrane of the gram-negative bacteria among the gram-positive bacteria and gram-negative bacteria, which are the vaginitis bacteria, and selectively sterilizes the gram-negative bacteria,
The naturally-derived phenolic compound lowers the bactericidal power of the octenidine against the gram-positive bacteria to control the sterilization range of the octenidine,
The bubble forming agent forms bubbles so that the bactericidal action of the octenidine can be activated,
The bubble-retaining agent suppresses the dissipation of water of the vulvar cleaner composition and at the same time maintains the bubbles formed by the bubble-forming agent, the vulva cleaner composition.
상기 옥테니딘은,
옥테니딘염산염(Octenidine dihydrochloride)인 외음부 세정제 조성물.
According to claim 1,
The octenidine is
A vulvar cleaning composition that is octenidine dihydrochloride.
상기 천연유래 페놀류 화합물은,
티몰 및 멘톨로 이루어진 군에서 선택되는 어느 1종의 물질 또는 1종 이상의 물질을 포함하는 외음부 세정제 조성물.
According to claim 2,
The naturally-derived phenolic compound,
A vulva cleaner composition comprising any one material or one or more materials selected from the group consisting of thymol and menthol.
상기 기포 형성제는,
코코베타인, 소듐라우로일귀리아미노산, 라우릴설페이트, 폴리소로베이트 및 라우라민옥사이드 중 선택되는 어느 1종의 물질 또는 1종 이상의 물질을 포함하는 외음부 세정제 조성물.
According to claim 3,
The foam forming agent,
A vulva cleaner composition comprising any one or more substances selected from cocobetaine, sodium lauroyl oat amino acid, lauryl sulfate, polysorbate and lauramine oxide.
상기 기포 유지제는,
글리세린인 외음부 세정제 조성물.
According to claim 4,
The foam retaining agent,
A vulvar cleanser composition that is glycerin.
상기 기포 유지제는,
상기 외음부 세정제 조성물이 유효성분으로 상기 코카미도프로필베타인을 함유하는 경우에만 상기 외음부 세정제 조성물에 함유되는 외음부 세정제 조성물.
According to claim 6,
The foam retaining agent,
The vulva cleaning composition contained in the vulvar cleaning composition only when the vulvar cleaning composition contains the cocamidopropyl betaine as an active ingredient.
상기 소취제는,
사탕수수 추출물, 편백나무 추출물, 레몬 추출물, 유칼리툽스 추출물 및 제올라이트 중 선택되는 어느 하나의 물질을 포함하는 외음부 세정제 조성물.
According to claim 7,
The deodorant,
A vulva cleaner composition comprising any one material selected from sugar cane extract, cypress tree extract, lemon extract, eucalyptus extract, and zeolite.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220158288A KR102516049B1 (en) | 2022-11-23 | 2022-11-23 | Vulvar cleaning composition that targets vaginitis bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220158288A KR102516049B1 (en) | 2022-11-23 | 2022-11-23 | Vulvar cleaning composition that targets vaginitis bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102516049B1 true KR102516049B1 (en) | 2023-03-31 |
Family
ID=86005597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220158288A Active KR102516049B1 (en) | 2022-11-23 | 2022-11-23 | Vulvar cleaning composition that targets vaginitis bacteria |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102516049B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160015718A (en) * | 2014-07-31 | 2016-02-15 | 이은선 | Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide |
KR20170005407A (en) * | 2014-03-28 | 2017-01-13 | 가마 헬스케어 리미티드 | A liquid antimicrobial composition |
-
2022
- 2022-11-23 KR KR1020220158288A patent/KR102516049B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170005407A (en) * | 2014-03-28 | 2017-01-13 | 가마 헬스케어 리미티드 | A liquid antimicrobial composition |
KR20160015718A (en) * | 2014-07-31 | 2016-02-15 | 이은선 | Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012347739B2 (en) | Biocidal compositions and methods of using the same | |
EP1740166B1 (en) | Therapeutic antimicrobial compositions and methods | |
DE69533724T2 (en) | COMPOSITION FOR INACTIVATING SWEETENERS IN LIQUIDS | |
US6673374B2 (en) | Pharmaceutical compositions and methods for managing skin conditions | |
KR101555341B1 (en) | Antibiotic wet tissue, and manufacturing method thereof | |
RU2465891C2 (en) | Antibacterial compositions, products and methods of their application | |
EP2937101A1 (en) | Semi-fluidic composition for lubricating, moisture retaining, disinfecting, sterilizing and method using the same | |
KR20150097560A (en) | Botanical antimicrobial compositions | |
EP3355848B1 (en) | Alcohol-based skin sanitizer having microbicidal properties | |
MX2007010908A (en) | ANTIMICROBIAL COMPOSITIONS THAT INCLUDE ESTERES OF HYDROXICARBOXYL ACIDS. | |
KR102373422B1 (en) | Composition for vaginal cleaning including functional peptides | |
KR20170040524A (en) | A method wipes containing the composition without the irritation on bamboo fabric | |
SE1650162A1 (en) | Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants. | |
KR102625331B1 (en) | Composite for antibacterial and deodorant agent using ionized minerals and persimmon leaf extract and other natural materials | |
KR20080081633A (en) | Antibacterial Soap Composition | |
KR102516049B1 (en) | Vulvar cleaning composition that targets vaginitis bacteria | |
US20150157583A1 (en) | Pharmaceutical Composition | |
US20020106399A1 (en) | Antimicrobial wipe | |
KR102241761B1 (en) | A composition having a fast-acting sterilizing effect at room temperature | |
CN103110541A (en) | All-natural washing-free disinfectant hand sanitizer | |
EP3515409B1 (en) | Complex and compositions for the treatment of ophthalmic and dermatological diseases | |
US9855205B2 (en) | Use of zinc coceth sulfate as an antibacterial agent against propionibacterium acnes | |
CN117751948A (en) | Composite disinfectant and preparation method and application thereof | |
KR102159018B1 (en) | Composition of natural-borne antifungals and moisturizers | |
KR102481754B1 (en) | Antibacterial and deodorant composition including galla rhois |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20221123 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20221204 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20221123 Patent event code: PA03021R01I Comment text: Patent Application |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221223 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230315 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230327 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20230327 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |